Airos Medical, Inc., headquartered in the United States, is a pioneering force in the medical technology industry, specialising in innovative respiratory solutions. Founded in 2015, the company has rapidly established itself as a leader in the development of advanced aerosol delivery systems, catering to both healthcare professionals and patients. With a focus on enhancing drug delivery efficiency, Airos Medical's core products include state-of-the-art nebulisers and inhalation devices that stand out for their precision and user-friendly design. The company has achieved significant milestones, including partnerships with major healthcare providers and recognition for its commitment to improving patient outcomes. Airos Medical continues to solidify its market position through ongoing research and development, ensuring it remains at the forefront of respiratory care innovation.
How does Airos Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Airos Medical, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Airos Medical, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures for Scope 1, Scope 2, and Scope 3 emissions. Consequently, there are no documented reduction targets or climate commitments available at this time. The company has not established any initiatives or pledges related to climate action, nor does it inherit emissions data from a parent or related organization. As such, Airos Medical's current climate impact and commitments remain unspecified within the available information.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Airos Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

